COMMUNIQUÉS West-GlobeNewswire

Dermira to Present at the 8th Annual SVB Leerink Global Healthcare Conference
21/02/2019
MENLO PARK, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Allscripts announces fourth quarter and 2018 full-year results
21/02/2019
Record fourth quarter bookings of $531 million up 69% from the prior year period Fourth quarter GAAP diluted EPS of $2.14; growth of 11% in non-GAAP diluted EPS to $0.20 Full year 2018 GAAP diluted EPS of $2.04; growth [...]
Cytokinetics Reports Fourth Quarter 2018 Financial Results
21/02/2019
Company Provides 2019 Financial Guidance and Expected Milestones Reduced Operating Expenses vs. 2018; Over Two Years of Cash Based on Current Burn Rate Interim Analysis for GALACTIC-HF on Track for 1H 2019 Results from [...]
Trillium Announces Proposed Public Offering of Common Share Units and Series II Non-Voting Convertible First Preferred Share Units
21/02/2019
TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of [...]
Exactus to Attend 15th Annual PDS Super Conference
21/02/2019
Largest Gathering of Independent Pharmacy Owners in US GLEN ALLEN, Va., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) , a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) [...]
Sienna Announces 2019 Annual and Special Meeting
21/02/2019
MARKHAM, Ontario, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) today announced that it will be hosting its 2019 annual and special meeting of shareholders on [...]
Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen
21/02/2019
First commercial program under Bavarian Nordic and Janssen Vaccines & Prevention B.V. collaboration advancing into clinical trials A therapeutic vaccine may represent a novel approach for early treatment and [...]
Melinta Therapeutics Announces One-for-Five Reverse Stock Split
21/02/2019
NEW HAVEN, Conn., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial [...]
SuperSonic Imagine will present its Aixplorer® MACH 30 ultrasound system at the 25th European Congress of Radiology (ECR 2019)
21/02/2019
in Vienna, Austria, from 27 February to 3 March 2019 AIX-EN-PROVENCE, France, Feb. 21, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814, PEA-PME eligible), a company specialising in ultrasound [...]
SuperSonic Imagine présentera son échographe Aixplorer® MACH 30 lors de la 25ème édition du Congrès Européen de Radiologie (ECR) 2019
21/02/2019
à Vienne en Autriche du 27 février au 3 mars 2019 AIX-EN-PROVENCE, France, 21 févr. 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814, éligible PEA-PME), société spécialisée dans l’imagerie [...]
VitalHub Announces Intention to Enter the Patient Flow Market Through Acquisition Strategy
21/02/2019
TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that it has imminent plans to enter the rapidly growing global patient flow market through a [...]
iCAD to Showcase ProFound AI™ Solution for Digital Breast Tomosynthesis at ECR 2019
21/02/2019
Currently pending CE Mark, ProFound AI technology for 2D mammography will also be previewed NASHUA, N.H., Feb. 21, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing [...]
Ohr Pharmaceutical Regains Compliance with NASDAQ Listing Requirements
21/02/2019
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) today announced that it received notice from The Nasdaq Stock Market LLC indicating that the Company has regained compliance with the [...]
Nova Leap Health Corp. Named #10 2019 TSX Venture Performer
21/02/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- NOVA [...]
Tabula Rasa HealthCare Announces Launch and Location of New Scientific Precision Pharmacotherapy Research & Development Institute
21/02/2019
MOORESTOWN, N.J. and ORLANDO, Fla., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced the [...]
Mapi Pharma to Host Key Opinion Leader Meeting on Long Acting Glatiramer Acetate (GA Depot) for Primary Progressive Multiple Sclerosis and New Treatments for MS
21/02/2019
Analyst Lunch and Live Webcast on Tuesday, March 5th at 12 Noon ET NESS ZIONA, Israel, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, clinical late stage biopharmaceutical company, announced [...]
Xbrane Biopharma AB: Alessandro Sidoli and Saeid Esmaeilzadeh decline re-election for 2019
21/02/2019
Press release 2019-02-21 Xbrane Biopharma AB (publ) (" Xbrane ") has today been informed by the Nomination Committee that Alessandro Sidoli and Saeid Esmaeilzadeh have declined re-election at the Annual General Meeting [...]
Rebirth of a Heart Valve: Franciscan Health Surgeon First in World to Use Device
21/02/2019
Clinical Trial Tests Advanced Application of an ECM® Cardiac Valve at Heart Center INDIANAPOLIS, Indiana, Feb. 21, 2019 (GLOBE NEWSWIRE) -- A patient who received a first-in-the-world tricuspid valve procedure as part [...]
MolecularMD is acquired by ICON
21/02/2019
PORTLAND, Ore. and CAMBRIDGE, Mass., Feb. 21, 2019 (GLOBE NEWSWIRE) -- MolecularMD Corporation, a molecular diagnostic specialty laboratory that enables the development and commercialisation of precision medicines in [...]

Pages